VIDEO: Pilot examine yields wide selection of efficient, tolerable verapamil doses for migraine

June 17, 2022

1 min watch


Chen Y, et al. Pharmacogenomics — One step nearer to precision medication in headache? A pilot, exploratory examine of the impact of pharmacogenomic phenotypes on the sufficient dosing of Verapamil for migraine prevention. Offered at: American Headache Society annual scientific assembly; June 9-12, 2022; Denver.

Disclosures: Chen stories no related monetary disclosures.

We have been unable to course of your request. Please strive once more later. When you proceed to have this concern please contact [email protected].

DENVER — Verapamil was proven to be tolerable for migraine prevention at a most dose of 20 mg to 480 mg per day, Yi-Chieh Chen, PharmD, mentioned on the American Headache Society’s annual scientific assembly.

“We discovered a variety of minimally efficient and tolerable verapamil doses in a cohort with varied pharmacogenomic phenotypes,” Chen, of the Mayo Clinic in Rochester, Minnesota, mentioned.



Leave a Reply